H Kaminski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
H Kaminski has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
C Richmonds
2 shared publicationsF Lin
2 shared publications- Linda L. Kusner
George Washington University
2 shared publications M Medof
2 shared publicationsBenjamin W. Hughes
Department of Neurology, Case Western University School of Medicine, 10900 Euclid Avenue, Cleveland, OH 44106, USA
1 shared publicationZ Li
1 shared publication
Latest Publications
- 1 December 2006
- Published by Elsevier in Experimental Neurology
- Vol. 202 (2) , 287-293
Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia
- 1 December 2006
- Published by Elsevier in Experimental Neurology
- Vol. 202 (2) , 287-293
Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia
- 14 October 2005
- Published by Wiley in Muscle & Nerve
- Vol. 33 (4) , 445-461
Molecular architecture of the neuromuscular junction
The neuromuscular junction (NMJ) is a complex structure that serves to efficiently communicate the electrical impulse from the motor neuron to the skeletal muscle to signal contraction. Over the last 200 years, technological advances in microscopy allowed visualization of the existence of a gap between the motor neuron and skeletal muscle that necessitated the existence of a messenger, which proved to be acetylcholine. Ultrastructural analysis identified vesicles in the presynaptic nerve terminal, which provided a beautiful structural correlate for the quantal nature of neuromuscular transmission, and the imaging of synaptic folds on the muscle surface demonstrated that specializations of the underlying protein scaffold were required. Molecular analysis in the last 20 years has confirmed the preferential expression of synaptic proteins, which is guided by a precise developmental program and maintained by signals from nerve. Although often overlooked, the Schwann cell that caps the NMJ and the basal lamina is proving to be critical in maintenance of the junction. Genetic and autoimmune disorders are known that compromise neuromuscular transmission and provide further insights into the complexities of NMJ function as well as the subtle differences that exist among NMJ that may underlie the differential susceptibility of muscle groups to neuromuscular transmission diseases. In this review we summarize the synaptic physiology, architecture, and variations in synaptic structure among muscle types. The important roles of specific signaling pathways involved in NMJ development and acetylcholine receptor (AChR) clustering are reviewed. Finally, genetic and autoimmune disorders and their effects on NMJ architecture and neuromuscular transmission are examined. Muscle Nerve, 2005
- 14 October 2005
- Published by Wiley in Muscle & Nerve
- Vol. 33 (4) , 445-461
Molecular architecture of the neuromuscular junction
The neuromuscular junction (NMJ) is a complex structure that serves to efficiently communicate the electrical impulse from the motor neuron to the skeletal muscle to signal contraction. Over the last 200 years, technological advances in microscopy allowed visualization of the existence of a gap between the motor neuron and skeletal muscle that necessitated the existence of a messenger, which proved to be acetylcholine. Ultrastructural analysis identified vesicles in the presynaptic nerve terminal, which provided a beautiful structural correlate for the quantal nature of neuromuscular transmission, and the imaging of synaptic folds on the muscle surface demonstrated that specializations of the underlying protein scaffold were required. Molecular analysis in the last 20 years has confirmed the preferential expression of synaptic proteins, which is guided by a precise developmental program and maintained by signals from nerve. Although often overlooked, the Schwann cell that caps the NMJ and the basal lamina is proving to be critical in maintenance of the junction. Genetic and autoimmune disorders are known that compromise neuromuscular transmission and provide further insights into the complexities of NMJ function as well as the subtle differences that exist among NMJ that may underlie the differential susceptibility of muscle groups to neuromuscular transmission diseases. In this review we summarize the synaptic physiology, architecture, and variations in synaptic structure among muscle types. The important roles of specific signaling pathways involved in NMJ development and acetylcholine receptor (AChR) clustering are reviewed. Finally, genetic and autoimmune disorders and their effects on NMJ architecture and neuromuscular transmission are examined. Muscle Nerve, 2005
- 1 October 2004
- Published by Elsevier in Experimental Neurology
- Vol. 189 (2) , 333-342
Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis
- 1 October 2004
- Published by Elsevier in Experimental Neurology
- Vol. 189 (2) , 333-342
Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis